Slides
[April 29] CTO LIVE_Severance Hospital, Seoul, Korea: Case #8
- Operator : Yasumi Igarashi
1st Operator: Yasumi Igarashi / 2nd Operator: Hoyoun Won
Brief Case Summary
45-year-old male patient underwent direct PCI (RCA) for STEMI (inferior) 2 years ago. Also, there was LAD CTO lesion, 4 days later, 2nd stage LAD CTO intervention was tried with antegrade approach but failed.
Past Medical History
- Previous MI: Y
- Previous CABG : N
- Previous PCI: Y (July 2017)
s/p PCI at RCA(ultimaster 3.5x24)
- Other: HTN, dyslipidemia
Demographic Characteristics
- Diabetes: N
- Hypertension: Y
- Hyperlipidemia: Y
- Smoking: N
- Family History: N
- Age: 45
- Sex: Male
Clinical Presentation
Stable angina [select one]
Exercise stress test positive result at stage IV
(with ST depression suggestive of ischemic change)
Non-invasive Studies
Echocardiography
RWMA at RCA and LAD territory, EF=42%
Treadmill test
Stage IV positive with ST depression
Cardiac Catheterization Findings
Total occlusion of mLAD (TIMI 0)
Collateral flow from PD to dLAD, OM to dLAD (G2)
Patent previous stents at mRCA
Case Notes
Target Lesion(s)
CTO at mLAD
Adjunctive Medication
- ASA: Y
- LMWH: Y
- Clopidogrel: Y
- Heparin: N
- Nitrates: Y
- IIb/IIIa: N
- Other: bisoprolol 1.25mg QD, Ezetimibe 10mg QD, Rosuvastatin 20mg QD
Heart CT (2018.03.15)
pLAD, noncalcified plaques, severe stenosis (>70%).
mLAD, total occlusion
Direct PCI at RCA(2016.08)
Stent : Ultimaster 3.5x24 at mRCA
CTO intervention at LAD(2016.09)
Wire was removed after confirm wire at false lumen
Final angio(2016.09)
F/U angio(2017.07.26)
- Previous MI: Y
- Previous CABG : N
- Previous PCI: Y (July 2017)
s/p PCI at RCA(ultimaster 3.5x24)
- Other: HTN, dyslipidemia
- Diabetes: N
- Hypertension: Y
- Hyperlipidemia: Y
- Smoking: N
- Family History: N
- Age: 45
- Sex: Male
Exercise stress test positive result at stage IV
(with ST depression suggestive of ischemic change)
Echocardiography
RWMA at RCA and LAD territory, EF=42%Treadmill test
Stage IV positive with ST depressionCollateral flow from PD to dLAD, OM to dLAD (G2)
Patent previous stents at mRCA
Target Lesion(s)
CTO at mLAD- ASA: Y
- LMWH: Y
- Clopidogrel: Y
- Heparin: N
- Nitrates: Y
- IIb/IIIa: N
- Other: bisoprolol 1.25mg QD, Ezetimibe 10mg QD, Rosuvastatin 20mg QD
mLAD, total occlusion
Stent : Ultimaster 3.5x24 at mRCA
Wire was removed after confirm wire at false lumen
Leave a comment